| | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C14H9ClN2O3S |
| Molar mass | 320.75 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Tenidap was a COX/5-LOX inhibitor and cytokine-modulating anti-inflammatory drug candidate [1] that was under development by Pfizer as a promising potential treatment for rheumatoid arthritis, [2] but Pfizer halted development after marketing approval was rejected by the FDA in 1996 [3] due to liver and kidney toxicity, which was attributed to metabolites of the drug with a thiophene moiety that caused oxidative damage. [4]